Inventor
Prissette Marine
US8 patents
Patents
8 patentsUS11781131B2Oct 10, 2023
CRISPR/Cas dropout screening platform to reveal genetic vulnerabilities associated with tau aggregation
REGENERON PHARMA5 citations73
US11845931B2Dec 19, 2023
CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
REGENERON PHARMA4 citations72
US12110502B2Oct 8, 2024
Models of tauopathy
REGENERON PHARMA1 citations69
US11845957B2Dec 19, 2023
Models of tauopathy
REGENERON PHARMA2 citations69
US12209238B2Jan 28, 2025
CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
REGENERON PHARMA1 citations62
US12421512B2Sep 23, 2025
CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
REGENERON PHARMA0 citations60
US12391920B2Aug 19, 2025
Models of tauopathy
REGENERON PHARMA0 citations59
US12342801B2Jul 1, 2025
Methods for producing antigen-binding proteins against foreign antigens
REGENERON PHARMA0 citations49